enVVeno Medical to Present at Webull Financial Corporate Connect Webinar on Deep Venous Disease Treatment

enVVeno Medical (NVNO) will present at Webull Financial's Corporate Connect Webinar Series on August 21, 2025, led by CEO Robert Berman. The discussion will focus on advancements in deep venous disease treatment, particularly with the VenoValve and enVVe products. The webinar is part of a series for biotech and medtech companies taking place from August 19-21, 2025.

enVVeno Medical (NVNO), a leading medical device company focused on the treatment of deep venous disease, will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech on August 21, 2025. The virtual presentation, led by CEO Robert Berman, will delve into the advancements in deep venous disease treatment, particularly the company's lead products, the VenoValve and enVVe.

The webinar, scheduled to take place from 2:00 PM ET on August 21, 2025, is part of a broader virtual conference series for biotech and medical technology companies. It is an opportunity for investors and financial professionals to gain insights into the latest developments in the treatment of deep venous disease.

enVVeno Medical's VenoValve is a first-in-class surgical replacement venous valve designed to treat Deep Venous Insufficiency (DVI). The company is currently evaluating the VenoValve in the VenoValve U.S. pivotal study. Additionally, enVVeno is developing a non-surgical, transcatheter-based replacement venous valve called enVVe, which is designed to act as a one-way valve to assist in propelling blood up the leg and back to the heart and lungs. The company is performing the final testing necessary to seek approval for the pivotal trial for enVVe.

The Webull Financial Corporate Connect Webinar Series aims to provide a platform for biotech and medtech companies to connect with investors and share their innovations. Webull Financial, a leading online brokerage platform, is committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull is revolutionizing the way individuals approach investing.

Investors interested in attending the webinar can register through the provided link. For more information about enVVeno Medical and Webull Financial, please refer to the respective press releases and official websites.

References:
[1] https://www.stocktitan.net/news/NVNO/en-v-veno-medical-to-present-at-the-webull-financial-corporate-426u62j3qtsx.html
[2] https://finance.yahoo.com/news/envveno-medical-present-webull-financial-132100414.html
[3] https://www.biospace.com/press-releases/envveno-medical-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech